Results 101 to 110 of about 1,232,742 (295)
Risk management externalities in agrifood supply chains
American Journal of Agricultural Economics, EarlyView.Abstract Firms may under‐ or over‐invest in risk management from the social planner's perspective, resulting in a negative externality on other economic agents in the supply chain. The externality of risk management is particularly relevant for agrifood supply chains, which frequently experience disruptions and play a primary role in preventing major ...
Jeffrey Hadachek, Meilin Ma
wiley +1 more source
Advanced NanoBiomed Research, EarlyView.Engineered endotoxin‐free Escherichia coli were used to assemble poly(3‐hydroxybutyrate) (PHB) biopolymer particles displaying multiple conserved Burkholderia pseudomallei antigens via PhaC‐mediated surface presentation. Following formulation with poly(I:C), the particulate vaccines induced antigen‐specific humoral and cellular immune responses ...
Md. Tanvir Kabir +6 more
wiley +1 more source
Infection and Drug ResistanceMejbah Uddin Bhuiyan,1 John A Carter,2 Victoria Abbing-Karahagopian31GSK R&D, Siena, Italy; 2Evidence and Access, OPEN Health, Bethesda, MD, USA; 3GSK, Amsterdam, the NetherlandsCorrespondence: Mejbah Uddin Bhuiyan, GSK R&D, Via Fiorentina 1 ...
Bhuiyan MU +2 more
doaj
Live bacterial delivery systems for development of mucosal vaccines
, 2000 By expression of foreign antigens in attenuated strains derived from bacterial pathogens and in non-pathogenic commensal bacteria, recombinant vaccines are being developed that aim to stimulate mucosal immunity.
Zegers, N.D. +8 more
core
The Efficiency of Bacterial Vaccines on Mortality during the 'Spanish' Influenza Pandemic of 1918-19. [PDF]
Soc Hist Med, 2023 Roth DT.
europepmc +1 more source
Metabiotic Medicine of Symbiotic Corynebacteria: Prevention, Treatment and Immunological Safety
Эпидемиология и вакцинопрофилактика, 2019 Relevance. Acute respiratory diseases (ARD) occupy a leading position in infectious pathology. Patients who often suffer from the acute respiratory diseases, in most cases have an ENT pathology against the background of immunodeficiency state.
E. A. Shmeleva +2 more
doaj +1 more source
Current Progress in the Development of mRNA Vaccines Against Bacterial Infections
Bacterial infections have accompanied humanity for centuries. The discovery of the first antibiotics and the subsequent golden era of their discovery temporarily shifted the balance in this confrontation to the side of humans. Nevertheless, the excessive
Vasiliy Reshetnikov +4 more
core +1 more source
Russian vaccines against especially dangerous bacterial pathogens
, 2014 In response to the epidemiological situation, live attenuated or killed vaccines against anthrax, brucellosis, cholera, glanders, plague and tularemia were developed and used for immunization of at-risk populations in the Former Soviet Union.
Valentina A Feodorova +3 more
core +1 more source
Bacterial ghosts as adjuvant particles
, 2007 The development of more advanced and effective vaccines is of great interest in modern medicine. These new-generation vaccines, based on recombinant proteins or DNA, are often less reactogenic and immunogenic than traditional vaccines.
Jennelle M Kyd +11 more
core +1 more source
The tRNA‐Modification Geranyl‐2‐Thiouridine Enables RNA‐Lipid Association
Angewandte Chemie International Edition, EarlyView.We report the preparation of mono‐ to tri‐geranylated RNA and the association of the hydrophobic RNA with membranes for future efficient incorporation of RNA into liposomes. ABSTRACT The packaging of RNA in lipid nanoparticles for protection and delivery was key for the development of mRNA vaccines and therapeutics. Formulation requires the addition of
Johannes Singer +3 more
wiley +1 more source